Epigenetic reprogramming for ocular aging and disease: Mechanisms, biomarkers, and the road to the clinic

Junwon Lee1, Minseok Han2, Kaixiang Wang3

  • 1Paul F. Glenn Center for Biology of Aging Research, Department of Genetics, Blavatnik Institute, Harvard Medical School (HMS), 77 Avenue Louis Pasteur, Boston, MA, 02115, USA; Department of Ophthalmology, Yonsei University College of Medicine, Institute of Vision Research, Gangnam Severance Hospital, 211, Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.

PubMed

Insights

Epigenetic alterations drive eye aging and vision loss. Epigenetic reprogramming offers a promising therapeutic strategy to restore youthful function and vision in age-related blinding diseases.

Area of Science:

  • Ophthalmology
  • Epigenetics
  • Cellular Aging

Background:

  • Retinal neural cells are vulnerable to age-related damage due to limited regeneration.
  • Epigenetic alterations (DNA methylation, histone modifications) are key drivers of aging and diseases like glaucoma and age-related macular degeneration (AMD).
  • These epigenetic changes disrupt cellular identity and function, leading to irreversible vision loss.

Purpose of the Study:

  • To provide a comprehensive overview of ocular aging from an epigenetic perspective.
  • To examine the therapeutic potential and concerns of epigenetic reprogramming for vision restoration.
  • To discuss the future of rejuvenation therapies in ophthalmology.

Main Methods:

  • Review of accumulating evidence on epigenetic alterations in ocular aging.
  • Analysis of preclinical studies on epigenetic reprogramming for vision restoration.
  • Discussion of Yamanaka factors and chemical cocktails for epigenetic resetting.

Main Results:

  • Epigenetic reprogramming can reset dysregulated epigenetic landscapes, restoring cells to a more youthful state.
  • Preclinical studies demonstrate vision restoration in models of optic neuropathy via neuronal rejuvenation.
  • Epigenetic marks are reversible, offering a novel therapeutic avenue distinct from genetic mutations.

Conclusions:

  • Epigenetic reprogramming presents a promising therapeutic paradigm for age-related blinding diseases.
  • Rejuvenation therapies hold significant potential for restoring vision and improving ocular health.
  • Further research is needed to address concerns and optimize epigenetic reprogramming strategies in ophthalmology.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Design Example: Alignment of a Road Line Using GIS01:17

Design Example: Alignment of a Road Line Using GIS

The alignment of a road line using Geographic Information Systems (GIS) is a critical process in civil engineering, combining advanced technology with practical decision-making. This methodology begins with the collection of geospatial data, including information on land cover, geomorphology, drainage patterns, slope, and contour details. Such data is typically acquired through satellite imagery and GIS tools, offering a comprehensive understanding of the terrain.Once the data is gathered, it...
340
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
795
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351